Skip to main content
Clinical Trials/NCT00906737
NCT00906737CompletedNot Applicable

Targeted Lower Extremity Joint Training Effects on MS Gait Abnormalities

Mount Sinai Rehabilitation Hospital2 sites in 1 country18 target enrollmentStarted: April 1, 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
18
Locations
2
Primary Endpoint
Gait Parameters

Study Overview

Brief Summary

This study is being done to test the possible benefits of task-specific focused ankle training using the Ankle-Bot on subjects with Multiple Sclerosis who have "foot-drop." The study also compares the effectiveness of task-specific focused ankle training using the Ankle-Bot with conventional focused ankle therapy in improving the gait of subjects with MS.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
25 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Clinical Diagnosis of MS
  • EDSS level between 3.5 - 6.0
  • Unilateral foot-drop
  • Able to ambulate 25 ft. with no more than a unilateral assistive device

Exclusion Criteria

  • Lower extremity injuries that limit range of motion or function
  • Unable to demonstrate an understanding of the process of the study and/or fully understand instructions in order to safely participate in the study and use study equipment
  • Unable to fit safely and properly into the Ankle-Bot device

Outcomes

Primary Outcomes

Gait Parameters

Time Frame: Baseline, throughout study enrollment, and at 1 month and 3 month follow-up

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Mount Sinai Rehabilitation Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jennifer Fawcett

Research Manager

Mount Sinai Rehabilitation Hospital

Study Sites (2)

Loading locations...

Similar Trials

Effects of Targeted Lower Extremity Joint... | Clinical Trial